Log on / register
Feedback | Support | My details

Pre-publication history

Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection

José M Navarro-Jarabo email, Nuria Fernández email, Francisca L Sousa email, Encarnación Cabrera email, Manuel Castro email, Luz M Ramírez email, Robin Rivera email, Esther Ubiña email, Francisco Vera email, Isabel Méndez email, Francisco Rivas-Ruiz email, José L Moreno email and Emilio Perea-Milla email

BMC Gastroenterology 2007, 7:31doi:10.1186/1471-230X-7-31

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript22 Dec 2006
Reviewer's ReportGiovanni Cammarota10 Feb 2007
Reviewer's ReportTJ Borody19 Feb 2007
Reviewer's ReportColm O'Morain07 Mar 2007
Resubmission - Version 2ManuscriptAuthors' comments28 Mar 2007
Resubmission - Version 3Manuscript29 Mar 2007
Reviewer's ReportTJ Borody27 Apr 2007
Reviewer's ReportColm O'Morain21 May 2007
Resubmission - Version 6ManuscriptAuthors' comments05 Jul 2007
Resubmission - Version 7ManuscriptAuthors' comments20 Jul 2007
Resubmission - Version 8Manuscript24 Jul 2007
Resubmission - Version 9Manuscript25 Jul 2007
Accepted25 Jul 2007
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.